ACAD9 antibody
Principal name
ACAD9 antibody
Alternative names for ACAD9 antibody
ACAD-9, Acyl-CoA dehydrogenase family member 9, mitochondrial
Ncbi ID
9606, NP_054768, NM_014049, NP_054768.2, NP_766266.3, NM_172678
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of ACAD9 antibody
- Kit Component:
- - KN300690G1, Acad9 gRNA vector 1 in pCas-Guide vector
- KN300690G2, Acad9 gRNA vector 2 in pCas-Guide vector
- KN300690D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
"Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family." Zhang J., Zhang W., Zou D., Chen G., Wan T., Zhang M., Cao X. Biochem. Biophys. Res. Commun. 297:1033-1042(2002)
ACAD9 MaxPab polyclonal antibody. Western Blot analysis of ACAD9 expression in human liver.
Western Blot analysis of ACAD9 expression in transfected 293T cell line (H00028976-T01) by ACAD9 MaxPab polyclonal antibody.Lane 1: ACAD9 transfected lysate(68.31 KDa).Lane 2: Non-transfected lysate.
Human 721_B; WB Suggested Anti-ACAD9 Antibody. . Titration: 1.0 ug/ml. . Positive Control: 721_B Whole Cell; ACAD9 antibody - C-terminal region (ARP60788_P050) in Human 721_B cells using Western Blot
Western blot analysis of ACAD9 with Jurkat cell lysate.
Predicted cell location: Cytoplasm. Positive control: Human cervical and thyroid cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human cervical cancer tissue using ACAD9 antibody at dilution 1/10, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human cervical and thyroid cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using ACAD9 antibody at dilution 1/10, on the right is treated with the fusion protein. (Original magnification:x200)
Predicted cell location: Cytoplasm. Positive control: Human ovarian and thyroid cancer tissue. Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human ovarian cancer tissue using ACAD9 antibody at dilution 1/15, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human ovarian and thyroid cancer tissue. Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using ACAD9 antibody at dilution 1/15, on the right is treated with the fusion protein. (Original magnification:x200)
WB Suggested Anti-ACAD9 Antibody; Titration: 1.0 ug/ml; Positive Control: 721_B Whole Cell
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA318884 | ACAD9 antibody |
||||||
| Rabbit polyclonal anti-ACAD-9 antibody | |||||||
 |
Rabbit | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€353.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA321830 | ACAD9 antibody |
||||||
| Anti-ACAD9 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA321831 | ACAD9 antibody |
||||||
| Anti-ACAD9 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA343058 | ACAD9 (C-term) antibody |
||||||
| Rabbit Polyclonal Anti-ACAD9 Antibody | |||||||
 |
Rabbit | Aff - Purified | Hu | WB |
50 µg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP303235 | ACAD9 |
||||
| Recombinant protein of human acyl-Coenzyme A dehydrogenase family, member 9 (ACAD9) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€438.00
|
|
| OriGene Technologies, Inc. | |||||
|
|||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC203235L2V | Lenti ORF particles, ACAD9 (mGFP-tagged) - Human acyl-CoA dehydrogenase family, member 9 (ACAD9), nuclear gene encoding mitochondrial protein, transcript variant 1, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
| RC203235L1V | Lenti ORF particles, ACAD9 (Myc-DDK tagged) - Human acyl-CoA dehydrogenase family, member 9 (ACAD9), nuclear gene encoding mitochondrial protein, transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€969.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR209532L2V | Lenti ORF particles, Acad9 (GFP-tagged) - Mouse acyl-Coenzyme A dehydrogenase family, member 9 (Acad9), nuclear gene encoding mitochondrial protein, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,206.00
|
|
| OriGene Technologies, Inc. | ||
| MR209532L1V | Lenti ORF particles, Acad9 (Myc-DDK-tagged) - Mouse acyl-Coenzyme A dehydrogenase family, member 9 (Acad9), nuclear gene encoding mitochondrial protein, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
